Contineum Therapeutics
Varsha Dourado is currently serving as the Vice President of Business Development at Contineum Therapeutics since June 2021. Prior to this role, Varsha held positions at companies such as Secura Bio, Inc., Synthetic Genomics, and Viking Therapeutics, Inc., where Varsha specialized in business development and corporate development. With an educational background in Biological Sciences/Chemistry, Neuroscience, and an MBA in Technology Transfer, Varsha has extensive experience in the pharmaceutical and biotechnology industry, spanning over two decades.
Contineum Therapeutics
Contineum Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation and immunology (NI&I) indications with high unmet need. Contineum targets biological pathways associated with specific clinical disabilities, that once modulated, can demonstrably impact the course of disease.